• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ubc9 通过非 SUMOylation 依赖的方式促进乳腺癌细胞的侵袭和转移。

Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.

机构信息

Department of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, IL 62794, USA.

出版信息

Oncogene. 2010 Mar 25;29(12):1763-72. doi: 10.1038/onc.2009.459. Epub 2009 Dec 21.

DOI:10.1038/onc.2009.459
PMID:20023705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2845735/
Abstract

Ubc9 is an E2-conjugating enzyme that transfers the activated small ubiquitin-like modifier (SUMO) to protein substrates, and thus it has an important function in sumoylation-mediated cellular pathways. We have earlier reported that Ubc9 promotes tumor growth in the xenograft mouse model using breast cancer cell line MCF-7 in part through regulation of Bcl-2 expression. In this study, we show that ectopic expression of wild-type Ubc9 (Ubc9-WT) promotes cell invasion and metastasis. Surprisingly, the dominant negative mutant Ubc9 (Ubc9-DN) also causes the same phenotype, indicating that the ability of Ubc9 to promote invasion and metastasis is distinct from its ability to conjugate SUMO to protein substrates. Of considerable interest, several microRNAs such as miR-224 are regulated by Ubc9. Although ectopic expression of Ubc9 causes downregulation of miR-224, suppression of Ubc9 by Ubc9-siRNAs leads to its upregulation. We further show that miR-224 can inhibit cell invasion and directly targets CDC42 and CXCR4, and that suppression of CDC42 and CXCR4 by RNAi causes inhibition of Ubc9-mediated invasion. Together, these results show a molecular link between Ubc9 and the metastasis genes such as CDC42 and CXCR4, and thus provide new insight into the mechanism by which Ubc9 promotes tumor invasion and metastasis.

摘要

Ubc9 是一种 E2 连接酶,可将激活的小泛素样修饰物(SUMO)转移至蛋白质底物上,因此在 SUMO 介导的细胞途径中具有重要功能。我们之前的研究报告称,Ubc9 通过调节 Bcl-2 表达,在 MCF-7 乳腺癌细胞系的异种移植小鼠模型中促进肿瘤生长。在这项研究中,我们表明,野生型 Ubc9(Ubc9-WT)的异位表达可促进细胞侵袭和转移。令人惊讶的是,显性负突变体 Ubc9(Ubc9-DN)也会导致相同的表型,这表明 Ubc9 促进侵袭和转移的能力与其将 SUMO 缀合至蛋白质底物的能力不同。有趣的是,几种 microRNA,如 miR-224,受 Ubc9 调控。尽管 Ubc9 的异位表达导致 miR-224 下调,但 Ubc9-siRNAs 对 Ubc9 的抑制导致其上调。我们进一步表明,miR-224 可抑制细胞侵袭,并直接靶向 CDC42 和 CXCR4,而 RNAi 对 CDC42 和 CXCR4 的抑制会导致 Ubc9 介导的侵袭受到抑制。总之,这些结果表明 Ubc9 与转移基因(如 CDC42 和 CXCR4)之间存在分子联系,从而为 Ubc9 促进肿瘤侵袭和转移的机制提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b9/2845735/bba3054f79c9/nihms159159f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b9/2845735/3ada1e68e11c/nihms159159f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b9/2845735/b643907f2a6a/nihms159159f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b9/2845735/11527398c777/nihms159159f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b9/2845735/d41c79e9c6e3/nihms159159f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b9/2845735/bc9c4dbf382f/nihms159159f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b9/2845735/bba3054f79c9/nihms159159f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b9/2845735/3ada1e68e11c/nihms159159f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b9/2845735/b643907f2a6a/nihms159159f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b9/2845735/11527398c777/nihms159159f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b9/2845735/d41c79e9c6e3/nihms159159f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b9/2845735/bc9c4dbf382f/nihms159159f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b9/2845735/bba3054f79c9/nihms159159f6.jpg

相似文献

1
Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.Ubc9 通过非 SUMOylation 依赖的方式促进乳腺癌细胞的侵袭和转移。
Oncogene. 2010 Mar 25;29(12):1763-72. doi: 10.1038/onc.2009.459. Epub 2009 Dec 21.
2
Ubc9 promotes invasion and metastasis of lung cancer cells.Ubc9 促进肺癌细胞的侵袭和转移。
Oncol Rep. 2013 Apr;29(4):1588-94. doi: 10.3892/or.2013.2268. Epub 2013 Feb 1.
3
MicroRNA-mediated regulation of Ubc9 expression in cancer cells.微小RNA介导的癌细胞中Ubc9表达的调控
Clin Cancer Res. 2009 Mar 1;15(5):1550-7. doi: 10.1158/1078-0432.CCR-08-0820. Epub 2009 Feb 17.
4
Regulation of bcl-2 expression by Ubc9.泛素结合酶9对bcl-2表达的调控
Exp Cell Res. 2006 Jun 10;312(10):1865-75. doi: 10.1016/j.yexcr.2006.02.017. Epub 2006 Mar 29.
5
MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.MEL-18与热休克因子2(HSF2)及小泛素样修饰蛋白E2结合酶9(UBC9)相互作用,以抑制HSF2的小泛素样修饰(SUMO化)。
J Biol Chem. 2008 Mar 21;283(12):7464-9. doi: 10.1074/jbc.M707122200. Epub 2008 Jan 21.
6
Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues.Ubc9,一种单一的小泛素样修饰物(SUMO)E2 连接酶,在正常组织和恶性组织中的表达分析。
Hum Pathol. 2010 Sep;41(9):1286-98. doi: 10.1016/j.humpath.2010.02.007. Epub 2010 Jun 18.
7
A role for Ubc9 in tumorigenesis.泛素结合酶9(Ubc9)在肿瘤发生中的作用。
Oncogene. 2005 Apr 14;24(16):2677-83. doi: 10.1038/sj.onc.1208210.
8
MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.MCRS1过表达可促进非小细胞肺癌的上皮-间质转化和转移,而miR-129*可特异性抑制MCRS1过表达。
Mol Cancer. 2014 Nov 6;13:245. doi: 10.1186/1476-4598-13-245.
9
S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers.S-腺苷甲硫氨酸调节鼠肝和人类癌症中泛素连接酶 9 蛋白的表达和 sumoylation。
Hepatology. 2012 Sep;56(3):982-93. doi: 10.1002/hep.25701. Epub 2012 Jul 12.
10
Estrogen receptor alpha and nuclear factor Y coordinately regulate the transcription of the SUMO-conjugating UBC9 gene in MCF-7 breast cancer cells.雌激素受体 alpha 和核因子 Y 协同调节 MCF-7 乳腺癌细胞中 SUMO 连接酶 UBC9 基因的转录。
PLoS One. 2013 Sep 27;8(9):e75695. doi: 10.1371/journal.pone.0075695. eCollection 2013.

引用本文的文献

1
UBC9 overexpression promotes proliferation and metastasis in gastric cancer via ATF2.UBC9过表达通过ATF2促进胃癌的增殖和转移。
World J Surg Oncol. 2025 Jul 9;23(1):270. doi: 10.1186/s12957-025-03922-y.
2
SUMOylation is a Translatable Target in Hypoxic MNPs Regulating Retinal Vasculopathy.SUMO化修饰是调节视网膜血管病变的缺氧微小神经胶质细胞中的一个可翻译靶点。
Adv Sci (Weinh). 2025 Aug;12(31):e03505. doi: 10.1002/advs.202503505. Epub 2025 May 31.
3
Elevated UBC9 expression and its oncogenic role in colorectal cancer progression and chemoresistance.

本文引用的文献

1
MicroRNA-mediated regulation of Ubc9 expression in cancer cells.微小RNA介导的癌细胞中Ubc9表达的调控
Clin Cancer Res. 2009 Mar 1;15(5):1550-7. doi: 10.1158/1078-0432.CCR-08-0820. Epub 2009 Feb 17.
2
p53 represses c-Myc through induction of the tumor suppressor miR-145.p53通过诱导肿瘤抑制因子miR-145来抑制c-Myc。
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3207-12. doi: 10.1073/pnas.0808042106. Epub 2009 Feb 6.
3
Micromanagers of malignancy: role of microRNAs in regulating metastasis.恶性肿瘤的微观管理者:微小RNA在调控转移中的作用
UBC9表达升高及其在结直肠癌进展和化疗耐药中的致癌作用。
Sci Rep. 2025 Mar 17;15(1):9123. doi: 10.1038/s41598-025-93868-8.
4
Deciphering the Epigenetic Symphony of Cancer: Insights and Epigenetic Therapies Implications.解析癌症的表观遗传交响乐:见解与表观遗传治疗启示。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241250317. doi: 10.1177/15330338241250317.
5
Repression of the SUMO-conjugating enzyme UBC9 is associated with lowered double minutes and reduced tumor progression.小泛素样修饰蛋白连接酶UBC9的抑制与双微体数量减少及肿瘤进展减缓相关。
Cancer Biol Ther. 2024 Dec 31;25(1):2323768. doi: 10.1080/15384047.2024.2323768. Epub 2024 Mar 11.
6
Ubiquitin‑conjugating enzymes as potential biomarkers and therapeutic targets for digestive system cancers (Review).泛素连接酶作为消化系统癌症的潜在生物标志物和治疗靶点(综述)。
Oncol Rep. 2023 Mar;49(3). doi: 10.3892/or.2023.8500. Epub 2023 Feb 17.
7
The UBC9/SUMO pathway affects E-cadherin cleavage in HPV-positive head and neck cancer.UBC9/小泛素样修饰蛋白(SUMO)途径影响人乳头瘤病毒(HPV)阳性头颈癌中E-钙黏蛋白的切割。
Front Mol Biosci. 2022 Aug 12;9:940449. doi: 10.3389/fmolb.2022.940449. eCollection 2022.
8
Construction and validation of a two-gene signature based on SUMOylation regulatory genes in non-small cell lung cancer patients.基于 SUMOylation 调控基因构建并验证非小细胞肺癌患者的两基因signature。
BMC Cancer. 2022 May 23;22(1):572. doi: 10.1186/s12885-022-09575-4.
9
Integrated In Silico Analyses Identify PUF60 and SF3A3 as New Spliceosome-Related Breast Cancer RNA-Binding Proteins.整合的计算机模拟分析确定PUF60和SF3A3为新的与剪接体相关的乳腺癌RNA结合蛋白。
Biology (Basel). 2022 Mar 22;11(4):481. doi: 10.3390/biology11040481.
10
The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer.下一个前沿:泛素化、SUMO 化和 NEDDylation 在癌症中的转化发展。
Int J Mol Sci. 2022 Mar 23;23(7):3480. doi: 10.3390/ijms23073480.
Trends Genet. 2008 Sep;24(9):448-56. doi: 10.1016/j.tig.2008.06.004. Epub 2008 Jul 31.
4
Modulation of PLAGL2 transactivation activity by Ubc9 co-activation not SUMOylation.通过Ubc9协同激活而非SUMO化作用调节PLAGL2反式激活活性。
Biochem Biophys Res Commun. 2008 Sep 26;374(3):570-5. doi: 10.1016/j.bbrc.2008.07.064. Epub 2008 Jul 23.
5
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.miR-200家族通过直接靶向E-钙黏蛋白转录抑制因子ZEB1和ZEB2来抑制上皮-间质转化和癌细胞迁移。
J Biol Chem. 2008 May 30;283(22):14910-4. doi: 10.1074/jbc.C800074200. Epub 2008 Apr 14.
6
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.微小RNA-200家族通过靶向E-钙黏蛋白抑制因子锌指E盒结合蛋白1(ZEB1)和锌指E盒结合蛋白2(ZEB2)来决定癌细胞的上皮表型。
Genes Dev. 2008 Apr 1;22(7):894-907. doi: 10.1101/gad.1640608.
7
REST maintains self-renewal and pluripotency of embryonic stem cells.REST维持胚胎干细胞的自我更新和多能性。
Nature. 2008 May 8;453(7192):223-7. doi: 10.1038/nature06863. Epub 2008 Mar 23.
8
Selective blockade of microRNA processing by Lin28.Lin28对微小RNA加工的选择性阻断
Science. 2008 Apr 4;320(5872):97-100. doi: 10.1126/science.1154040. Epub 2008 Feb 21.
9
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.微小RNA-21在侵袭和转移过程中靶向肿瘤抑制基因。
Cell Res. 2008 Mar;18(3):350-9. doi: 10.1038/cr.2008.24.
10
The guardian's little helper: microRNAs in the p53 tumor suppressor network.守护者的小帮手:p53肿瘤抑制网络中的微小RNA
Cancer Res. 2007 Dec 1;67(23):11099-101. doi: 10.1158/0008-5472.CAN-07-2672.